Nonclonal neutrophil responses after successful treatment of myelodysplasia with low-dose 5-aza-2’-deoxycytidine (decitabine)
To access this article, please choose from the options below
PII: S0145-2126(04)00130-4
doi:10.1016/j.leukres.2004.04.002
© 2004 Elsevier Ltd. All rights reserved.
